similarly , under our envance technologies ' dragon fire research platform , we are developing patented bioherbicide products and applications to help us address a global $ 18 billion market for non-selective herbicides .
we expect interest expense will be similar to 2020 levels , and our overall tax rate should be in the mid-20 % range .
its invigorate line as an [ indecipherable ] approved consortium of 22 bacteria that have been developed to promote multiple benefits including , soil -- include improvement of the soil microbial community on many global crops and soil conditions , facilitating nitrogen absorption and nutrient uptake , while supporting root biomass and plant health .
first , we invested a total of $ 36 million , acquiring two businesses , making a strategic equity investment , continuing to develop our manufacturing capability , and advancing our simpas delivery systems .
taking all that together , availability at december 31 , 2020 is $ 85 million , as compared to $ 27 million for the same time last year .
secondly , we paid down debt by $ 43 million .
with nearly 150 pending and issued patents in multiple countries , agrinos is proving to be an excellent fit for american vanguard .
over the past several months , we have screened over 130,000 active ingredients in our lab , and have identified a manageable number of promising candidates for further development and possible commercialization .
in our us crop market , sales increased by approximately 19 % as a result of strong sales of products sold into the midwest row crop market such as , our smartbox , counter , and aztec brands , as growers reacted to increased blood pressure and on to increased commodity pricing for soybeans and corn .
as you can see from the chart , net factory costs for the year amounted to approximately 2.8 % of sales .
and at the bottom line , we 've seen a very strong finish to 2020 and reported net income , up 12 % compared to 2019 .
including working capital , we generated $ 89 million from operations , which is about nine times what we have achieved on a -- in average for the prior two years .
and note , that at the end of 2020 , our debt to ebitda ratio was 2.2 times .
for the full year 2020 , despite some movements by category , gross margin percentage was in line with 2019 , at 38 % .
finally , our international sales grew by 15 % .
our fourth quarter non-crop gross margin declined from 42 % in q4 of 2019 to 35 % in 2020 , driven primarily by the reduced market demand for dibrom already discussed , and by the lower factory activity rate .
